Methods of computing costs of prophylaxis and therapy of parasitic diseases in domestic animals: costs and cost analysis
Kolacz, J.W.
Wiadomosci Parazytologiczne 21(2): 329-338
1975
ISSN/ISBN: 0043-5163 PMID: 1136505 Document Number: 91545
Document emailed within 1 workday
Related Documents
Eaton, J.W.; Menzies, N.A.; Stover, J.; Cambiano, V.; Chindelevitch, L.; Cori, A.; Hontelez, J.A.C.; Humair, S.; Kerr, C.C.; Klein, D.J.; Mishra, S.; Mitchell, K.M.; Nichols, B.E.; Vickerman, P.; Bakker, R.; Bärnighausen, T.; Bershteyn, A.; Bloom, D.E.; Boily, M-Claude.; Chang, S.T.; Cohen, T.; Dodd, P.J.; Fraser, C.; Gopalappa, C.; Lundgren, J.; Martin, N.K.; Mikkelsen, E.; Mountain, E.; Pham, Q.D.; Pickles, M.; Phillips, A.; Platt, L.; Pretorius, C.; Prudden, H.J.; Salomon, J.A.; van de Vijver, D.A.M.C.; de Vlas, S.J.; Wagner, B.G.; White, R.G.; Wilson, D.P 2014: Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models Lancet. Global health 2(1): e23-e34Zarnowski, E.; Chowaniec, W.; Fagasiński, A.; Machnicka, B. 1975: Currently available possibilities of uniform diagnostic methods of comparative determination of the incidence and intensity of parasitic infections in domestic animals Wiadomosci Parazytologiczne 21(2): 323-328
Jerome, D.; Laurent, C.; Catherine, B.; Didier, S.; Bertrand, C.; Muriel, R.; Joseph, M.; Olivier, Z.; Thiery, P.; Claude, C.J.an 2002: Costs of hospital management of hepatitis C virus cirrhosis in France Comparison between real costs and diagnosis related groups based costs Results of a multicentric study carried out on 267 consecutive patients in 1998 Hepatology 36(4 Part 2): 587A
Von Ferber, L.; Köster, I.; Hauner, H. 1996: Direct costs of ambulatory treatment of diabetes mellitus. Comparison of observed costs with estimated costs of adherence to the treatment standard Medizinische Klinik 91(12): 802-808
Schrag, D.; Weeks, J. 1999: Costs and cost-effectiveness of colorectal cancer prevention and therapy Seminars in Oncology 26(5): 561-568
Rabøl, R.; Kolbye, A.; Andersen, S.Ejdrup. 2003: Drug costs in departments of internal medicine. An analysis of costs for patients and departments Ugeskrift for Laeger 165(15): 1565-1568
Petrelli, F.; Grappasonni, I.; Kračmarová, L.; Cioffi, P.; Tayebati, S.K.; Esposito, L. 2013: Rare diseases in Italy: analysis of the costs and pharmacotherapy Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 62(4): 159-162
Marshall, M. 1989: Social medicine significance, costs, course, therapy and prognosis of venous diseases Versicherungsmedizin 41(3): 89-97
Czechowicz-Janicka, K.; Orlewska, E.; Tobota, Z.; Anielska, E.; Dyczkowska, A. 2000: Analysis of glaucoma therapy costs in Poland. I--population of the Mazovian District Klinika Oczna 102(6): 417-422
Rácil, Z.; Mayer, J.; Kocmanová, I.; Wagnerová, B.; Winterová, J.; Folber, F.; Lengerová, M.; Moulis, M.; Zácková, D.; Smardová, L.; Janíková, A.; Navrátil, M.; Dvoráková, D.; Vorlícek, J. 2008: Invasive aspergillosis in hematooncological patients: advantages and disadvantages of various diagnostic methods, treatment options and financial costs of therapy Vnitrni Lekarstvi 54(2): 157-168
Giannico, L.; Vannugli, R. 1977: Analysis of benefits and costs in the eradication of transmissible diseases of endemic character with special reference to poliomyelitis Minerva Medica 68(63): 4201-4209
2012: Costs for traditional meds static while specialty drug costs soar Managed Care 21(6): 47
Rautenberg, R. 1983: Determining allowable reimbursable costs: PERT as a tool for hospital costs under Social Security Healthcare Financial Management: Journal of the Healthcare Financial Management Association 37(1): 48; 50
Rudofsky, G.; van Laak, H.H. 1994: Treatment costs of peripheral arterial occlusive disease in Germany: a comparison of costs and efficacy Journal of Cardiovascular Pharmacology 23(Suppl): S22-S25
Peña, C.; Pujol, M.; Pallarés, R.; Corbella, X.; Vidal, T.; Tortras, N.; Ariza, J.; Gudiol, F. 1996: Estimation of costs attributable to nosocomial infection: prolongation of hospitalization and calculation of alternative costs Medicina Clinica 106(12): 441-444
Fogel, R.W.; Costa, D.L. 1997: A theory of technophysio evolution, with some implications for forecasting population, health care costs, and pension costs Demography 34(1): 49-66
Lubell, J. 2007: Revenue, costs rise 7% annually. Census data, AHRQ report sicker patients add to costs Modern Healthcare 37(50): 8-9
Prast, J.; Oppelt, P.; Shamiyeh, A.; Shebl, O.; Brandes, I.; Haas, D. 2013: Costs of endometriosis in Austria: a survey of direct and indirect costs Archives of Gynecology and Obstetrics 288(3): 569-576
Müller, H.; Stähr, R.; Klapper, W. 1976: The problem of cost calculation of communicable diseases. II. Report: methods of cost analysis of communicable diseases Zeitschrift für Arztliche Fortbildung 70(12): 669-671
Weldon, C.B.; Trosman, J.; Schink, J.C. 2012: Cost of cancer: there is more to it than containing chemotherapy costs Oncology 26(11): 1116; 1118